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Polymorphisms in the human circadian clock gene PERIOD3 (PER3) are associated with
a wide variety of phenotypes such as diurnal preference, delayed sleep phase disorder,
sleep homeostasis, cognitive performance, bipolar disorder, type 2 diabetes, cardiac
regulation, cancer, light sensitivity, hormone and cytokine secretion, and addiction.
However, the molecular mechanisms underlying these phenotypic associations remain
unknown. Per3 knockout mice (Per3−/−) have phenotypes related to activity, sleep
homeostasis, anhedonia, metabolism, and behavioral responses to light. Using a
protocol that induces behavioral differences in response to light in wild type and
Per3−/− mice, we compared genome-wide expression in the eye and hypothalamus
in the two genotypes. Differentially expressed transcripts were related to inflammation,
taste, olfactory and melatonin receptors, lipid metabolism, cell cycle, ubiquitination, and
hormones, as well as receptors and channels related to sleep regulation. Differentially
expressed transcripts in both tissues co-localized with Per3 on an ∼8Mbp region
of distal chromosome 4. The most down-regulated transcript is Prdm16, which is
involved in adipocyte differentiation and may mediate altered body mass accumulation
in Per3−/− mice. eQTL analysis with BXD mouse strains showed that the expression
of some of these transcripts and also others co-localized at distal chromosome 4, is
correlated with brain tissue expression levels of Per3 with a highly significant linkage
to genetic variation in that region. These data identify a cluster of transcripts on
mouse distal chromosome 4 that are co-regulated with Per3 and whose expression
levels correlate with those of Per3. This locus lies within a topologically associating
domain island that contains many genes with functional links to several of the diverse
non-circadian phenotypes associated with polymorphisms in human PER3.
Keywords: mouse, circadian, topological associating domain, metabolism, transcriptome
INTRODUCTION
The circadian timing system defines biological timing and its synchronization to the environmental
24-h light/dark cycle. The central pacemaker in the suprachiasmatic nuclei (SCN) of the
hypothalamus entrains to environmental cues and synchronizes peripheral clocks in tissues and
organs to regulate 24-h rhythms in physiology and behavior. A set of highly conserved circadian
clock genes and their products interact in the molecular feedback loops that determine circadian
clock function (Archer and Oster, 2015).
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The Period3 (Per3) gene is a component of the circadian
clock. Its presence is not required for central circadian clock
function, although absence of PER3 in mice has subtle effects
on the circadian period of locomotor activity, and larger effects
on the period of circadian gene expression in ex vivo dissociated
SCN cells and peripheral organ cell cultures (Shearman et al.,
2000; Bae et al., 2001; Pendergast et al., 2012; Ramanathan et al.,
2014). Absence of functional PER3 protein in Per3 knock out
mice (Per3−/−) has also been associated with reduced inhibition
by light of locomotor activity (negative masking), and changes in
the overall amount of locomotor activity and sleep homeostasis
(van der Veen and Archer, 2010; Hasan et al., 2011).
We have shown that a primate-specific, variable number,
tandem repeat (VNTR), coding region polymorphism in human
PER3 is associated with diurnal preference, delayed sleep phase
disorder, sleep homeostasis, increased body mass index (BMI) in
people who sleep late during work days, cognitive performance,
fMRI-assessed brain activity, lower intelligence in people with
long sleep duration during work days, and cardiac regulation
(Archer et al., 2003; Viola et al., 2007, 2012; Groeger et al.,
2008; Vandewalle et al., 2009, 2011; Lazar et al., 2012; Lo
et al., 2012). Others have reported associations with bipolar
disorder (Benedetti et al., 2008), schizophrenia (Karthikeyan
et al., 2014a), white matter integrity (Bollettini et al., 2017),
type 2 diabetes (Karthikeyan et al., 2014b), cancer (Alexander
et al., 2015), light sensitivity (Chellappa et al., 2012), hormone
secretion (Wirth et al., 2013), cytokine secretion (Guess et al.,
2009), and addiction (Zou et al., 2008). In addition, we have
also shown that transgenically humanizing mouse Per3 with the
VNTR polymorphism phenocopies some aspects of human sleep
homeostasis such as increased theta power during wake and delta
power during sleep (Hasan et al., 2014). Thus, PER3 is associated
with a wide range of phenotypes, but the molecular mechanisms
underlying these pleiotropic effects remain unknown.
Because Per3 is a circadian clock gene that has been associated
with light-dependent phenotypes, here we characterized
differential gene expression between wild type and Per3−/−
mice in hypothalamic and whole eye tissue during an ultradian
light/dark protocol that produced different behavioral responses
in the genotypes. Many transcripts that were differentially
expressed in Per3−/− mice localized to a cluster of genes
around Per3 on distal chromosome 4. Expression quantitative
trait loci (eQTL) analyses identified strong linkage between
Per3 expression and genetic variation within the same distal
chromosome 4 cluster and high correlation between Per3
expression and the expression of genes within the cluster.
Differentially expressed transcripts were related to non-circadian
functions including sleep homeostasis and identify genetic
targets that might underlie some of the diverse phenotypes
associated with PER3.
MATERIALS AND METHODS
Animals
Male Period3 knockout mice (Per3−/−) (Shearman et al., 2000)
and their wild-type (WT) litter mates on a C57Bl/6J background
were bred at the University of Surrey, as described previously
(van der Veen and Archer, 2010). Genotyping was performed
as previously described (Shearman et al., 2000). Throughout all
experiments, mice were kept under controlled environmental
conditions [20–22◦C ambient temperature, 55 ± 10% relative
humidity, light intensity at cage bottom was ∼170 mW/m2
(∼50 lux)]. All experimental procedures were approved by the
University of Surrey Animal Ethics Committee and carried out
under a United Kingdom Home Office License.
Animal Experiments
To investigate differential gene expression between WT and
Per3−/− mice, animals were subjected to an ultradian light/dark
paradigm that we have previously published (van der Veen and
Archer, 2010). Male, adult WT and Per3−/− mice [N = 8 per
genotype, age = 66.0± 3.4 days (mean± SEM)] were individually
housed in running wheel cages in a 12 h light/12 h dark cycle
(LD 12:12) for 10 days. Mice were subsequently exposed to 17
cycles of an LD 3.5:3.5 starting at lights-on on day 11. In the
second hour of the last ultradian light cycle, mice were killed by
cervical dislocation and tissue (brain and whole eye) was collected
in RNAlater stabilization reagent (Qiagen, United Kingdom) and
frozen at −80◦C until further analysis. Running wheel data were
collected throughout the experiment (ClockLab, Actimetrics,
Wilmette, IL, United States) and used to confirm previously
observed significant attenuation of behavioral suppression by
light in Per3−/− mice (van der Veen and Archer, 2010).
To investigate genotype differences in body mass
accumulation, normal diet-fed male WT and Per3−/− mice
were individually housed under LD 12:12 at 4 weeks of age
[28.0 ± 0.9 days (mean ± SEM)] and switched to either a
10 kcal% (control) or 45 kcal% (high) fat diet (D12450B and
D12451, respectively, Research Diets, Inc., NJ, United States).
The LD 12:12 cycle was advanced by 4 h every 7 days (Davidson
et al., 2006), and this protocol was continued for 14 weeks. Body
mass and food consumption was established twice per week
(N = 8 per genotype, per diet). Body mass data for two WT mice
on high fat diet was removed from the analysis due to instability
of body mass during the protocol. Data was statistically tested
using Proc MIXED in SAS (Cary, NC, United States).
Tissue Specific Differential Gene
Expression
The whole-genome transcriptome was quantified by microarrays
as previously described (Hasan et al., 2014). In short, for both
Per3−/− and WT mice (N = 8 per genotype) mRNA was
purified from a frozen block of hypothalamic tissue and whole
eye using the RNeasy Mini Kit (Qiagen, United Kingdom).
Hypothalamic blocks were prepared by placing the frozen
brain on ice, and then ventral to dorsal cutting a square
(∼2 × 2 mm) boxed around the optic chiasm in the horizontal
plane [starting at 0.02 mm caudal to Bregma in Paxinos and
Franklin (2001)], trimmed to a depth of ∼2 mm. This block
included the SCN of the hypothalamus. RNA quantity was
measured spectrophotometrically (Nanodrop, Thermo Fisher
Scientific, Waltham, MA, United States) and integrity was quality
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controlled using an Agilent Bioanalyzer (Agilent Technologies
United Kingdom Limited, United Kingdom). RNA was used
to prepare labeled cRNA, which was hybridized to Agilent
Whole Mouse Genome slides (60 mer, 4 × 44K features), and
array features were extracted using Agilent Feature Extraction
Software (Agilent Technologies). The results of these array
data have been made publically available at the NCBI Gene
Expression Omnibus database. Expression levels were analyzed
using GeneSpring version 12 (Agilent Technologies). Differential
expression of probes and genes was quantified both as the
fold change expression between genotypes, and significantly
differential expression between genotypes were identified using
unpaired T-Tests with an asymptotic P-value computation with
Benjamini–Hochberg correction for multiple testing. As a second
approach to identify differential gene expression between WT
and Per3−/− mice, we applied the RankProdIt analysis, as
described previously (Laing and Smith, 2010). One sample for
Per3−/− whole eye was removed due to hybridization errors.
Quantitative PCR
Male, adult WT and Per3−/− mice [N = 8 per genotype,
age = 65.0 ± 1.6 days (mean ± SEM)] were individually housed
in running wheel cages in an LD 12:12 for 19 days, after which
they were exposed to constant darkness. On the second day of
constant darkness (DD), three mice per genotype were culled
every 4 h at circadian time (CT) 0, 4, 8, 12, 16, and 20 (CT0 = time
of previous lights on). Mice were killed by cervical dislocation
and tissues were harvested in RNAlater stabilization reagent
(Qiagen, United Kingdom) and frozen at −80◦C until further
analysis. RNA was extracted using the RNeasy Mini Kit (Qiagen,
Hilden, Germany) according to the manufacturer’s instructions.
For each sample, the relative levels of expression of Prdm16 and
housekeeping gene large ribosomal protein subunit P0 (Rplp0)
were measured using Taqman qPCR and quantified using the
delta delta CT method. The qPCR primers and probe for each
gene are shown in Supplementary Table S1.
Expression Quantitative Trait Loci
Analyses
eQTL were computed with the use of GeneNetwork1 (Mulligan
et al., 2017). In GeneNetwork there are six record ID options to
select that target different regions of Per3 mRNA. Gene Network
recommends selecting a record ID that targets an exonic region
so for the analyses presented here, we selected record 1421086_at,
which targets the last three exons and proximal 3′ UTR of Per3.
eQTLs for Per3 in the mouse BXD RI family were mapped for
Brain mRNA [UCHSC BXD Whole Brain M430 2.0 (Nov06)
RMA (Saba et al., 2006)], Eye mRNA [Eye M430v2 (Sep08)
RMA], and Liver mRNA [GSE16780 UCLA Hybrid MDP Liver
Affy HT M430A (Sep11) RMA (Bennett et al., 2010)]. Using
the GeneNetwork mapping tool, we computed the likelihood
ratio statistics (LRS score) for 1421086_at using interval mapping
(1000 permutations). We next computed the sample correlations
to establish the top 500 correlated (Pearson’s R) expression
regions of 1421086_at for the eye mRNA dataset, and the
1genenetwork.org (accessed June 2019).
chromosomal locations of the their maximal LRS locations. We
established the gene location of the specific transcripts that have
a maximal LRS in one of five chromosomal regions with maximal
LRS counts > 50, and for each of the five groups calculated
whether the number of linked genes per chromosome were
more, or less than expected: Expected per chromosome = (#
genes chromosome/# genes genome) × # genes in cluster;
Fraction of expected = (observed per chromosome/expected per
chromosome)− 1.
Bioinformatics
Gene ontology (GO) enrichment for biological processes and
molecular functions associated with gene expression data was
performed using Webgestalt 2019 (Zhang et al., 2005; Liao
et al., 2019). We performed over representation analysis with
the geneontology database using mouse gene symbol annotation
and the mouse genome as a reference. P values were Benjamini–
Hochberg corrected and a false discovery rate (FDR) of <0.05
was used to select significant terms. Gene/protein interaction
networks for differentially expressed genes were generated
using STRING v11 with the confidence of interaction set to
“high.” Unconnected nodes in the generated networks were
not displayed. For the topologically associating domain (TAD)
analysis, we used the Hi-C browser at Penn State University2.
Mouse assembly mm9 was used together with mouse cortex Hi-C
data (Dixon et al., 2012) at a resolution of 40 kb.
RESULTS
Differential Gene Expression in the Eye
and Hypothalamus of Per3−/− Mice
To investigate the contribution of Per3 to molecular pathways
that could underlie some of its diverse associated phenotypes,
we performed transcriptomic analysis of hypothalamic and
whole eye tissue from WT and Per3−/− mice. When mice
are exposed to light during their active dark period, they
reduce locomotor activity (negative masking) and we have
previously shown reduced negative masking in Per3−/− mice
compared to WT when exposed to an ultradian light/dark
protocol (3.5 h light/3.5 h dark) (van der Veen and Archer,
2010). We therefore collected tissue samples from mice on
the same ultradian protocol. Mice were kept on an LD 12:12
cycle for 10 days and then exposed to 17 cycles of LD
3.5:3.5. Tissues for transcriptomics were collected during the
17th ultradian light cycle, which corresponded to the prior
circadian mid-active phase, a time when we previously saw the
greatest behavioral difference between genotypes (Figure 1A).
Analysis of wheel-running activity during the ultradian protocol
(Figure 1B) confirmed our previous observation of reduced
suppression of activity in Per3−/− mice during the ultradian
light periods compared with WT (P < 0.001 for genotype∗time,
post hoc P < 0.05).
Transcriptome analyses identified 74 probes in the
hypothalamus (mapping to 67 annotated transcripts) that
2promoter.bx.psu.edu/hi-c
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FIGURE 1 | Ultradian light/dark protocol and activity behavior. Light-dark protocol of Per3−/− and WT mice (A), indicating that mice were killed in the 17th ultradian
light-dark cycle, corresponding to circadian time (CT) 18.5. (B) Group mean total behavioral activity in the dark (left) and light (right) as percentage of total activity in
baseline during ultradian light-dark cycles, as a function of CT. Cosinor fits to activity (WT = black, Per3−/− = red) indicated significantly higher levels of activity
during the light phase for Per3−/− mice, with maximal predicted differences in negative behavioral masking at the time of sampling. Please note that all asterisks are
single but several adjacent time points are significant at the P < 0.05 level.
were differentially expressed > twofold between the genotypes,
of which 35 were upregulated and 39 were downregulated
(Supplementary Data File S1). In the eye, there were 75 probes
(mapping to 71 annotated transcripts) that were differentially
expressed > twofold between the genotypes (28 upregulated,
47 downregulated) (Supplementary Data File S1). By far
the most down-regulated (>sevenfold) transcript in both
hypothalamus and eye in Per3−/− was Prdm16 (PR/SET domain
16), a transcriptional regulator that functions in adipose cell
differentiation (Seale et al., 2007), neurogenesis (Baizabal et al.,
2018), and transforming growth factor beta (TGFβ) signaling
(Zeng et al., 2017).
Large average fold changes in expression may also have large
variance in expression values and therefore insignificant p values
and ranking probes according to corrected p values identified
fewer differentially expressed transcripts. Conversely, small
variance in expression values can give rise to significant p values
but small associated fold changes. Thus, either approach applied
on its own can fail to detect biologically relevant differential gene
expression. We therefore also applied an approach that combines
fold change and significance levels to determine differentially
expressed gene ranking (Xiao et al., 2014).
The top 50 differentially expressed transcripts identified
from this combined analysis for each tissue are shown in the
heatmaps of Figure 2A (also Supplementary Data File S2)
where expression values are shown for all individual mice. This
analysis identified a larger overlap of differentially expressed
transcripts between the tissues (13 transcripts in common) and
also highlighted multiple transcripts for the same gene being
differentially expressed in the eye. Twenty-three of the transcripts
that code for 17 known genes are co-located in an ∼8 Mb
region (149.000–157.000 Mbp) surrounding Per3 on mouse
distal chromosome 4 (Figure 2B) and the majority of these are
downregulated in Per3−/− mice, including Per3 itself. These
data suggest that the expression levels of genes within this co-
located cluster are co-regulated with Per3 and predominantly
in a positive way.
Differentially expressed transcripts co-localized with Per3
were associated with glucose/fructose regulation (Slc2a5,
C1qtnf12), phospholipase activity (Cptp), RNA binding and
translation (Rpl22), DNA repair (Faap20), potassium channel
and cardiovascular function (Kcnab2, Rnf207), chromatin
modification (Prdm16, Phf13), and immune response (Spsb1,
Tnfrsf14). Some are also involved in diseases such as Alzheimer’s
(Clstn1) and deafness (Espn). If probes are simply ranked
according to uncorrected p value, this co-localization enrichment
increases to include 17 and 14 of the top-20 probes for the
hypothalamus and eye, respectively, and includes additional
transcripts of interest such as Dvl1 (Wnt signaling) and Park7
(Parkinson’s disease).
The combined fold change/p value analysis confirmed Prdm16
to be the most down-regulated transcript in both tissues. When
the expression levels of Prdm16 in both eye and hypothalamus are
compared for individual WT and Per3−/− mice, the very tight
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FIGURE 2 | Differential gene expression between WT and Per3−/− mice. (A) Top-50 differentially regulated microarray probes in the hypothalamus and whole eye of
WT, and Per3−/− mice. Each row depicts normalized transcript expression in biological replicates (N = 8 per genotype for hypothalamus, and N = 7 per genotype
for whole eye), and are top-to-bottom ordered from largest to smallest fold-change between WT and Per3−/− mice, in groups of up- and down-regulated probes.
Probes – or where possible associated gene names of probes – are indicated, and black lines connect the same probes/genes between tissues. Multiple probes
targeting the same gene in the eye are in bold. (B) Chromosome location of 17 genes represented in the probes from (A), which are all localized around Per3, on the
distal end (149–157 × 108bp) of mouse chromosome 4. Triangles point to loci of the probes, and shading indicates whether genes were differentially regulated in the
hypothalamus (black), whole eye (white), or both (gray).
clustering of expression values demonstrates the consistency of
this effect (Figures 3A,B). We also observed the down regulation
of Prdm16 by qPCR amplification in samples of whole eye tissue
collected at 4-hourly intervals across 24 h from WT and Per3−/−
mice that had been housed in constant darkness, which allows
the detection of intrinsic circadian rhythms in the absence of an
entraining light/dark cycle. The data show a circadian rhythm
in the expression of Prdm16 in WT mice and a significantly
down-regulated expression profile in Per3−/− mice (Figure 3C;
genotype effect P < 0.0001). These qPCR data independently
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FIGURE 3 | Individual microarrays and qPCR confirmation for differential
Prdm16 expression. Normalized microarray expression levels of Prdm16
mRNA in whole eye (A) and hypothalamus (B) of individual wild-type (black
circles) and Per3−/− (red squares; N = 7 per genotype). Large black circles
and red squares are the mean (±SEM, not visible) normalized expression
levels for WT and Per3−/−, respectively. (C) In vivo circadian expression
patterns of Prdm16 mRNA (mean ± SEM) was confirmed through qPCR
analysis in mouse whole eye, sampled across the circadian day (N = 8 per
genotype). Prdm16 mRNA exhibited circadian expression patterns in both WT
and Per3−/− mice, but overall levels in Per3−/− mice were significantly lower
(T-test, P < 0.05).
demonstrate in an alternative protocol, that PRDM16 is indeed
down-regulated in Per3−/− compared with WT mice.
Accumulated Weight Gain in Per3−/−
Mice
Several clock genes have been associated with metabolic
phenotypes in mice (Bass and Takahashi, 2010), and human
PER3 has been linked with BMI and obesity (Lazar et al., 2012;
Samblas et al., 2018). Thus, we wanted to investigate further
whether down-regulation of Prdm16 in Per3−/− mice could
affect metabolism and body mass. WT and Per3−/− mice were
fed either a normal or a high fat diet from 4 weeks of age for
a period of 14 weeks. Body weight and food consumption were
recorded twice per week. During the protocol, mice were housed
individually on an LD 12:12 cycle that was advanced by 6 h every
7 days, which represents a chronic jet-lag protocol shown to be
stressful in mice (Davidson et al., 2006). Although this is different
to the ultradian protocol used for the transcriptome experiment,
we chose this approach as being more suitable to identify a
metabolic phenotype difference between WT and Per3−/− mice
because exposure to continuously shifted light/dark schedules in
mice is associated with metabolic disorders (Kolbe and Oster,
2019). There was a significant effect of genotype, diet and time
on body mass accumulation (interaction P < 0.0001, post hoc
multiple comparisons P < 0.001–0.05 for WT vs. Per3−/− mice
in high fat diet). Compared to WT, Per3−/− mice accumulated
less body mass when fed on a high fat diet during weeks 4–
13 (Figure 4A). Both WT and Per3−/− mice consumed less
food when on the high fat diet compared to the normal diet
(Figure 4B), and Per3−/− mice consumed less than WT on both
diets (Figure 4B). This shows that PER3 associates with altered
body mass accumulation during early development.
Genes associated with biological pathways are likely to be
differentially expressed at varying levels. Thus, for GO pathway
level analysis we relaxed the fold change cut-off to include all
probes that were significantly differentially expressed between
genotypes, as determined by a rank products analysis. This
analysis identified 226 probes (103 up-regulated and 123 down
regulated in Per3−/− compared to WT) that mapped to 194
unique genes in whole eye, and 775 probes (299 up regulated
and 476 down regulated) that mapped to 672 unique genes in
hypothalamus (Supplementary Data File S3). GO enrichment
analysis (Webgestalt; Zhang et al., 2005; Liao et al., 2019) for the
differentially expressed genes in the eye revealed 14 significant
biological processes and molecular functions (FDR < 0.05)
including steroid hydroxylase activity, oxidoreductase activity,
fatty acid metabolic process, and inflammatory response
(Supplementary Data File S4). For the differentially expressed
genes in the hypothalamus, there were many more significant
GO terms and the top 40 ranked by FDR are shown in
Supplementary Data File S5. For the hypothalamus, biological
processes and molecular functions included response to oxygen-
containing compound, circulatory system development, cell
proliferation, double-stranded DNA binding, RNA polymerase
II regulatory region DNA binding, tissue development, and
transcription regulatory region DNA binding.
The differentially expressed transcripts identified by rank
products analysis also showed significant enrichment for
interaction networks (STRING v 11, analysis set for high
confidence; whole eye number of edges 85, expected number
36, enrichment P = 1.943e-12; hypothalamus number of edges
404, expected number 227, enrichment P = 4.44e-13) (Figures 5,
6). The interaction network for the eye contains a sub-network
centered around complement component (C3) with related
inflammatory functions and another sub-network with several
members related to cytochrome P450 metabolism, which were
also enriched in several of the terms in the GO analysis (Figure 5).
The interaction network for the hypothalamus (Figure 6)
contains several clusters of interest that include ubiquitination,
cell cycle and mitosis, taste, melatonin, and olfactory receptors.
Other clusters have functions that are closely related to sleep
including a cluster centered around prostaglandin synthase
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FIGURE 4 | Body mass accumulation in WT and Per3−/− mice. (A) Accumulative body mass gain in wildtype (sold black symbols) and Per3−/− (open red symbols)
mice, fed on normal (downward triangle) and high-fat (upward triangles) diet. The asterisks connected by the black line indicates a significantly (P < 0.001–0.05 for
post hoc multiple comparisons) higher accumulated body mass gain in wildtype mice, compared to Per3−/− mice on a high fat diet. (B) Individual, and boxplot
interquartile ranges of average food consumption for both genotypes on both diets, indicating that WT mice eat more food than Per3−/− mice (P < 0.05)
irrespective of diet, and that irrespective of genotypes, mice eat less when on a high-fat diet (P < 0.05). There were no significant interaction effects. *P < 0.05.
2 (Ptgs2) involved in lipid/fat metabolism (also containing
Adipoq, Adipor2, Prdm16, and Ucp1), and an elongated cluster
containing prolactin, growth hormone and growth hormone
receptor, thyroid stimulating hormone and thyroid stimulating
hormone receptor, prostaglandin D2 receptor, and adrenergic
and adenosine receptors. The densest cluster in the network
contains mainly extracellular matrix proteins with functions
related to circulatory activity (Figure 6).
Expression QTL Correlation Analysis
With Per3 in BXD Mice
Because of the co-localization with Per3 of a large proportion
of the differentially expressed genes in Per3−/− mice, we next
used expression eQTL database analysis (see text footnote 1)
to identify chromosomal loci where genetic variation correlated
with Per3 expression levels in multiple tissue experiments
from recombinant backcross strains of C57BL/6J and DBA/2J
(BXD) mice. We performed LRS (likelihood ratio statistic;
LRS = logarithm of the odds [LOD] × 4.61) score mapping
for Per3 gene expression for brain and peripheral tissue gene
expression datasets for BXD mice strains (see text footnote 1;
see section “Materials and Methods” for details). Many brain
regions showed a highly significant LRS peak for Per3 expression
on distal chromosome 4 at exactly the same region where
differentially expressed microarray transcripts co-localized with
Per3 in our data. These brain regions included the nucleus
accumbens, hippocampus, eye, cerebellum, prefrontal cortex, and
striatum. For convenience, in Figure 7A we show the results
of this mapping for whole brain, as well as eye and liver. It
should be noted that there is only one dataset available for
hypothalamic gene expression, which does not show a significant
LRS peak for Per3 expression on chromosome 4. The liver
dataset is characteristic of peripheral tissues that showed a
much reduced and often not significant LRS peak at distal
chromosome 4 for Per3 expression. Thus, this linkage appears
stronger in brain tissues. The LRS peak at chromosome 4 was
particularly significant for the eye (Figure 7A). Although, as
expected, this peak centers around Per3, it remains significant
for a far broader region of distal chromosome 4 that covers
many genes (Supplementary Figure S1), including those that
we showed to be co-regulated with Per3 in our transcriptomic
analyses (Figure 2).
We next used the BXD gene expression datasets to identify
genes whose expression showed a significant correlation with
Per3 expression levels. The top 500 transcripts whose expression
covaries with Per3 in the eye are listed in Supplementary
Data File S6. In the LRS map for Per3 expression in the eye
(Figure 7A), in addition to the main LRS peak at chromosome
4, there are also peaks that reach suggestive significance on
chromosomes 10, 12, 15, and 19. However, many of the most
significantly correlated transcripts from these analyses were also
located in the same region at distal chromosome 4 surrounding
Per3 (Figure 7B) and also had maximal LRS expression linkage
scores with genetic variation in the same region of chromosome
4 (Figure 7C). Although the majority of the transcripts showed
cis eQTL linkage, 19 of the top 100 transcripts had expression
linkage at chromosome 4 but were physically located on other
chromosomes, and four transcripts were located on chromosome
4 with linkage to other chromosomes. The P values for the
correlations listed in Supplementary Data File S6 are non-
corrected for multiple testing, but even when a recommended
three orders of magnitude are subtracted from the P values, 96 of
the top 100 correlations remain significant [see Supplementary
Figure S2a for example of gene expression scatter plot for the
highest ranked correlation apart from Per3 transcripts (Vamp3)].
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FIGURE 5 | Interaction network for differentially expressed eye transcripts. STRING v11 was used to generate gene/protein interaction networks from transcripts
differentially expressed in the eye, according to rank products analysis. The interaction confidence limit was set to high, thickness of edges corresponds to
confidence, and unconnected nodes are not displayed. Network clusters associated with inflammation and P450 metabolism are shown. The total number of edges
in the network was 85, the expected number derived from the input gene list (n = 194) was 36, and the corresponding enrichment p value was 1.943e-12.
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FIGURE 6 | Interaction network for differentially expressed hypothalamus transcripts. STRING v11 was used to generate gene/protein interaction networks from
transcripts differentially expressed in the hypothalamus, according to rank products analysis. The interaction confidence limit was set to high, thickness of edges
corresponds to confidence, and unconnected nodes are not displayed. Network clusters associated with functions of interest are indicated. The total number of
edges in the network was 404, the expected number derived from the input gene list (n = 672) was 227, and the corresponding enrichment p value was 4.44e-13.
In our transcriptomics data, Prdm16 was the most down-
regulated transcript in both hypothalamic and eye tissue in
Per3−/− mice. Several Prdm16 transcripts appear in the eye
Per3 gene expression correlation list (Supplementary Data
File S6). The Prdm16 transcript with the highest-ranking p
value has a strong positive correlation with Per3 expression
(Supplementary Figure S2b). While this agrees with our own
transcriptome data (i.e., low levels of Per3 expression are
associated with low levels of Prdm16 expression), it should be
noted that other Prdm16 transcripts have negative correlations
with Per3 expression.
The list of the top 500 transcripts whose expression covaried
with Per3 in the eye was submitted to Webgestalt for GO analysis.
This identified 322 unique coding genes which were enriched for
many significant GO terms for biological processes and molecular
functions that included kinase binding, ribonucleotide binding,
response to light stimulus, positive regulation of gene expression,
regulation of myelination, ubiquitin protein ligase binding, and
regulation of cell cycle (see Supplementary Data File S7 for top
40). Several of these terms show overlap with the node clusters
for the interaction network for differentially expressed genes
in the hypothalamus, e.g., cell cycle, ubiquitination, translation
(Figure 6). It should also be noted that the interaction network
for differentially expressed genes in the eye contained two
connected nodes for Mobp (myelin associated oligodendrocyte
basic protein) and Mbp (myelin basic protein) (Figure 4).
Although these two specific genes do not feature in the top 500
covarying genes from the BXD datasets, it nevertheless points to
a potential overlap in the regulation of molecular function.
DISCUSSION
In this study, we replicated the reduced negative masking
behavioral phenotype that we had previously observed in
the Per3−/− mice subjected to an ultradian light:dark cycle
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FIGURE 7 | eQTL analyses. (A) GeneNetwork was used to map the chromosomal locations of likelihood ratio statistics (LRS scores) for genetic variation linked with
Per3 expression (1421086_at) in brain, eye and liver using interval mapping. (B) The top 500 transcripts whose expression correlated with Per3 expression in eye
were extracted and their maximal LRS and number of traits at each location are shown in the figure. (C) We then looked at the chromosomes that contain
substantial enrichments of maximal expression linkage for the top 500 correlated mRNA transcripts shown in (B), and for each of those chromosomes we looked at
which transcripts exhibit these maximal LRS locations. For each of the chromosomes that exhibit substantial maximal linkage, we show the proportional enrichment
(fraction of expected, see section “Materials and Methods”) of linked transcripts for each chromosome in (C).
(van der Veen and Archer, 2010). We chose to use this behavioral
difference between WT and Per3−/− mice to investigate the
differential gene expression associated with the absence of
a functional PER3 protein in eye and hypothalamic tissue
within a light/dark protocol that we knew produced marked
differential behavioral responses between WT and Per3−/− mice.
However, we acknowledge that we cannot distinguish between
differential gene expression induced by this protocol and any
underlying differences in gene expression that may not be related
to the protocol, which would have required a transcriptomic
comparison at baseline LD 12:12 conditions. Nevertheless, we
chose the protocol to maximize the opportunity to detect
differential gene expression between the genotypes, which is
what we report here.
Analyses of differentially expressed transcripts identified
genes whose function were not related directly with
circadian rhythms but more generally with functions such
as transcription/translation, ubiquitination, cell cycle, and
metabolism. More specific functions were related to olfaction,
taste, lipid/fat regulation, ion channels and hormones and
hormone receptors. Some of these have been implicated with
sleep regulation and homeostasis and this agrees with our
previous findings for differential expression in humanized
mice expressing either the 4- or 5-repeat alleles for the human
PER3 VNTR polymorphism. Genes of particular interest
include those for prostaglandin endoperoxide synthase 2
(Ptgs2) and prostaglandin D2 receptor (Ptgdr), which has been
linked with NREM sleep regulation (Oishi et al., 2015). Ptgs2
is also expressed together with the brain specific sleep-loss
correlate Homer1a as part of the recovery mechanism from
glutamate-induced neuronal hyperactivity (Maret et al., 2007).
Polymorphisms in the adenosine receptor gene (Adora2a) affect
sleep homeostasis (Retey et al., 2007) and interact with the
PER3 VNTR polymorphism to determine cognitive performance
during sleep restriction (Rupp et al., 2013). Growth hormone (Gh,
Ghr), prolactin (Prl), and thyroid stimulating hormone (Tshb,
Tshr) are all associated with sleep/wake regulation, e.g., prolactin
and REM sleep (Machado et al., 2017), thyroid stimulating
hormone and sleep deprivation (Pereira and Andersen, 2014),
and relations between age-related growth hormone secretion
and REM sleep (Van Cauter et al., 2000). The melatonin receptor
Mtnr1a is differentially expressed in the hypothalamus and
has links with circadian rhythms and also with exhaustion in
shift workers (Sulkava et al., 2017), insomnia in schizophrenics
(Park et al., 2011), and with Alzheimer’s (Sulkava et al., 2018).
The human PER3 VNTR polymorphism has been linked with
myelination and brain structure (Bollettini et al., 2017; Dewandre
et al., 2018), and it is interesting that two genes associated with
myelination (Mobp, Mbp) were differentially expressed in the eye.
We showed that the most down-regulated gene in both eye
and hypothalamus in the Per3−/− mice was Prdm16 and, with
qPCR, we observed reduced circadian rhythmicity of PRDM16
in conditions of constant darkness in the eye. Prdm16 is located
close to Per3 on distal chromosome 4 and showed highly
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correlated levels of expression with Per3 in BXD lines. PRDM16
is a zinc finger transcription factor that regulates a range of
developmental processes that include the neocortex (Inoue et al.,
2017), cardiovascular system and hematopoiesis (Chi and Cohen,
2016), and brown fat development (Seale et al., 2007). PRDM16
influences brown fat development by regulating expression of
uncoupling protein 1, Ucp1 (Iida et al., 2015), which was also
differentially expressed in the hypothalamus. PRDM16 enhances
Ucp1 gene expression via a direct interaction with a subunit
(MED1) of the mediator component of the RNA polymerase
II complex (Iida et al., 2015). This regulation by PRDM16 also
involves interaction with thyroid hormones receptors at thyroid
receptor elements in gene promoters (Iida et al., 2015), which is
perhaps also relevant for the differential expression of Tshb and
Tshr that we observed in our data. It has also been shown that
binding of PRDM16 to MED1 alters chromatin structure and
regulates the activity of super-enhancers that drive expression
of co-regulated genes (Harms et al., 2014). Because PRDM16
was consistently down-regulated in both tissues, which was
confirmed with qPCR and agreed with the BXD expression
correlation data, we investigated if there was a body mass
phenotype in the Per3−/− mice. We indeed found that Per3−/−
mice accumulated less body mass than WT mice when fed on
a high-fat diet from age 4 weeks. Previously it has been shown
that Per3−/− mice (albeit on a different background and with
different lighting conditions) accumulated more body mass than
WT when fed a high-fat diet (Dallmann and Weaver, 2010).
However, that was only apparent from age 20 weeks and the
reduced body mass accumulation that we found in the Per3−/−
mice agrees with data from younger mice in the previous study.
Indeed, after 13 weeks in our study the difference in accumulated
body mass gain is no longer significant and it is possible that with
extended measurements we would have seen an increase in body
mass accumulation in the Per3−/− mice compared to WT mice,
as was observed in older mice in the previous study. Thus, the
influence of PER3/PRDM16 on body mass accumulation seems
to be age-dependent, but may also be strain dependent as has
been noted for metabolic phenotypes in other clock gene knock
outs (Johnston et al., 2009). It is also interesting to note that
both our study and the previous one by Dallmann and Weaver
observed reduced food intake in both genotypes in the high fat
diet compared to normal diet, and also reduced food intake in
Per3−/− mice compared to WT.
We found that there was a highly significant LRS linkage
peak between Per3 expression and genetic variation at distal
chromosome 4 and that the LRS peak width corresponded
almost exactly with the region where we identified differentially
expressed transcripts in the Per3−/− mice that colocalized
around Per3. The only other core circadian clock gene to show
a significant LRS peak for the BXD eye RNA dataset was Nr1d1
(Reverbα) but the LRS peak was located on chromosome 4 while
Nr1d1 itself is on chromosome 11. There was a suggestive LRS
peak for Clock at chromosome 1 that coincided exactly with the
locations of Per2 and Hdac4. Apart from Per3, none of the other
circadian clock genes were found to covary in expression with
other genes located in the same chromosomal region. However,
some of the other core clock genes did show corelated expression
with other known clock elements, whereas Per3 did not. For
example, the gene with expression most highly correlated with
that of Arntl was Clock, and the fourth and seventh highest
correlations were with Per2 and Dbp, respectively. Similarly, for
Per2 the second and third highest expression correlations were
with Tef and Dbp, respectively. Thus, unlike Per3, the expression
of other clock genes is closely linked with the expression of
other clock elements and not neighboring non-circadian genes.
These observations are consistent with what we know about
Per3 – it is a non-essential clock gene with many associated
non-circadian phenotypes.
Previously, we created knock in mice homozygous for either
the 4- or 5-repeat allele of the primate-specific human PER3
VNTR polymorphism (Hasan et al., 2014). We investigated
differential gene expression in the hypothalamus in those mice
after 12 h of sleep deprivation. We compared the lists of
significantly differentially expressed genes from this and the
previous experiment. From the Venn diagram in Supplementary
Figure S3 (see also Supplementary Table S2 for lists of
overlapping genes), we see that there is overlap between the
lists for the KO eye and hypothalamus from this study but less
overlap between those lists and the genes that were differentially
expressed between the 4- and 5-repeat homozygous mice for
the hypothalamus. It is also evident that there is little overlap
between the KO eye and hypothalamus and the genes that covary
with Per3 in the eye in the BXD mice, although there is more
overlap between those BXD genes and the differentially expressed
VNTR alleles. From this we can speculate that when Per3 is
present in BXD mice, there is a set of genes colocalized at
distal chromosome 4 whose expression is coregulated together
with Per3. The absence of PER3 protein only directly affects the
expression of a smaller number of genes in this region. Expression
of Per3 with either the 4- or 5-repeat alleles affects the expression
of a larger number of coregulated genes but again only a small
subset of the BXD covarying genes. This implies that PER3 itself
only directly influences a small subset of other genes in this
coregulated chromosomal region.
All of the data that we have presented here are consistent
with the hypothesis that much of the gene expression in the
distal region of mouse chromosome 4 is co-regulated. Such
chromosomal regions of transcriptional co-regulation have been
shown to be related directly with chromatin architecture whereby
chromosomal regions of closely interacting chromatin form
distinguishable units called TADs. Control elements within TADs
can enhance gene expression within the TAD and suppress
gene expression in a neighboring TAD (Dixon et al., 2016). In
mammals, neighboring TADs are often co-regulated in a super
structure whereby connecting chromatin loops produce strong
chromatin interaction between TADs, with neighboring TADs in
either active or inactive expression states (Szabo et al., 2019). To
investigate the possibility that distal chromosome 4 contains a
co-regulated TAD neighborhood, we used a Hi-C browser (see
section “Materials and Methods”) to show chromatin interaction
and associated predicted TADs in a published mouse cortex Hi-
C dataset (Dixon et al., 2012). The results confirm that there
is indeed an island of three interacting TADs at distal mouse
chromosome 4 that corresponds almost exactly with the region
(149–157 Mb) where we identified a cluster of differentially
expressed transcripts in mouse eye and hypothalamus in our data
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(Supplementary Figure S4). This also corresponds precisely with
the position and width of the eQTL LRS peak for Per3 expression,
and with the chromosomal position of genes whose expression in
BXD lines significantly covaries with Per3 expression.
Topologically associating domain boundaries are defined by
specific chromatin features including binding of protein elements
such as CCCTC-binding factor (CTCF) and cohesion complex
(Dixon et al., 2016). From the heatmap in Supplementary
Figure S4b, it can be seen that Per3 is located very close to
the boundary between two predicted neighboring TADs. The
Per3 functional knock out mouse was created using a PGK-NEO
cassette that replaced exon 3 and the intron between exon 3 and
exon 4, introducing a stop codon in all three reading frames,
resulting in undetectable levels of PER3 protein (Shearman et al.,
2000). However, addition of the cassette increased the detectable
size of the Per3 mRNA by 2 kb and expression levels of Per3
mRNA were significantly reduced in the suprachiasmatic nucleus
and skeletal muscle, which is in line with our reduced expression
for Per3 in the hypothalamus of Per3−/− mice. Thus, we cannot
exclude the possibility that insertion of an extra 2 kb in the Per3
KO transgene has somehow altered chromatin architecture in
this region and affected the TAD boundary dynamics, leading
to altered regulation of local gene expression, including that of
Per3 itself.
A similar TAD island is also present at the region of human
chromosome 1 that is syntenic with mouse distal chromosome
4, where PER3 is also positioned at the boundary between two
neighboring TADs. The human PER3 VNTR polymorphism
is an insertion of only 54 bp in exon 19 (in the current
human genome assembly GRCh38.p13) and rather than altering
chromatin structure and TAD dynamics, it seems more likely
that this coding-region polymorphism affects PER3 protein
function which leads to the observed phenotypic associations
(although the VNTR does overlap with a regulatory open
chromatin mark). However, the human genome assembly also
shows that the PER3 gene overlaps with a long non-coding RNA
(lncRNA) transcript (lncZ98884.1-201) present on the opposite
strand. The transcriptional start site of the lncRNA coincides
with PER3 exon 18, where there is also an H3K27Ac histone
acetylation mark and a DNaseI sensitivity site, which are both
markers of chromatin modification and accessibility associated
with regulatory elements at gene transcription start sites. Thus,
transcription of the lncRNA could be affected by the adjacent
PER3 VNTR. The function of this particular lncRNA is unknown,
but lncRNAs mainly regulate transcription and translation and
it is possible that this antisense transcript regulates PER3
expression in addition to other genes. The current mouse genome
annotation does not include an antisense lncRNA within Per3 but
this cannot be ruled out.
Some developmental diseases caused by chromosome
abnormalities have been shown to disrupt TAD architecture
that regulates developmental gene expression (e.g., F syndrome
caused by an inversion on chromosome 2; see Lupianez et al.,
2016, for review). Human 1p36 deletion syndrome is caused
by a chromosomal deletion in a region of chromosome 1 that
is syntentic with mouse distal chromosome 4. Developmental
abnormalities include intellectual disability, brain anomalies,
vision problems, hearing loss, facial anomalies, and heart defects
(Jordan et al., 2015). Disruption to several genes has been
associated with the syndrome, including PRDM16 and KCNAB2,
which were differentially expressed in the present study. Thus,
we hypothesize that 1p36 deletion disrupts the conserved TAD
architecture in this region.
We and others have previously shown that PER3 associates
with a wide range of non-circadian phenotypes. In this study,
we have demonstrated that the functional knock out of Per3 led
to changes in the expression of genes with functions related to
those phenotypes. A significant number of the co-regulated genes
also occur in close proximity to Per3 on distal chromosome 4,
where eQTL analyses show there is a significant linkage peak
that covers the same chromosomal location and many genes
in that region show correlated expression with Per3 in BXD
lines. Chromatin interaction analyses showed that this region
is a TAD superdomain which explains the local co-regulation
that we observed in both our data and the eQTL data. Thus,
expression of Per3 (and human PER3 at syntenic chromosome
1) is co-regulated with a number of neighboring genes which
presumably explains its association with a range of pleiotropic
phenotypes. The links between these phenotypes and human
disease underlines the relevance for a greater awareness of genetic
variation and regulation in this chromosomal region.
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